Exousia Bio (LMMY) Notes Payables (2022 - 2024)

Exousia Bio has disclosed Notes Payables across 3 years of filings, most recently posting $29000.0 for Q3 2024.

• Notes Payables for Q3 2024 came in at $29000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Aug 2024 was $29000.0 (changed 0.0% YoY), and the FY2024 annual result was $29000.0, changed 0.0% from the prior year.
• Notes Payables came in at $29000.0 for Q3 2024 at Exousia Bio, roughly flat from $29000.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $29000.0 in Q2 2022 to a low of $29000.0 in Q2 2022.
• The 3-year median for Notes Payables is $29000.0 (2022), against an average of $29000.0.
• Peak annual rise in Notes Payables reached 0.0% in 2023, while the deepest fall reached 0.0% in 2023.
• Exousia Bio's Notes Payables stood at $29000.0 in 2022, then changed by 0.0% to $29000.0 in 2023, then changed by 0.0% to $29000.0 in 2024.
• The last three Notes Payables figures came in at $29000.0 (Q3 2024), $29000.0 (Q2 2024), and $29000.0 (Q1 2024), per Business Quant data.